CN101804112A - 贯众乌梅中药组合物制备方法及应用 - Google Patents
贯众乌梅中药组合物制备方法及应用 Download PDFInfo
- Publication number
- CN101804112A CN101804112A CN 201010133555 CN201010133555A CN101804112A CN 101804112 A CN101804112 A CN 101804112A CN 201010133555 CN201010133555 CN 201010133555 CN 201010133555 A CN201010133555 A CN 201010133555A CN 101804112 A CN101804112 A CN 101804112A
- Authority
- CN
- China
- Prior art keywords
- rhizoma osmundae
- fructus mume
- chinese medicine
- extract
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 239000002131 composite material Substances 0.000 title abstract description 8
- 241001226187 Cyrtomium fortunei Species 0.000 title abstract 7
- 235000003385 Diospyros ebenum Nutrition 0.000 title abstract 7
- 241000792913 Ebenaceae Species 0.000 title abstract 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 156
- 239000000284 extract Substances 0.000 claims abstract description 62
- 239000000203 mixture Substances 0.000 claims abstract description 29
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims abstract description 25
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims abstract description 25
- 229930016911 cinnamic acid Natural products 0.000 claims abstract description 25
- 235000013985 cinnamic acid Nutrition 0.000 claims abstract description 25
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims abstract description 25
- 201000010099 disease Diseases 0.000 claims abstract description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 24
- 241000588724 Escherichia coli Species 0.000 claims abstract description 15
- 244000144977 poultry Species 0.000 claims abstract description 15
- 206010064097 avian influenza Diseases 0.000 claims abstract description 12
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 11
- 241000700605 Viruses Species 0.000 claims abstract description 9
- 241000606161 Chlamydia Species 0.000 claims abstract description 8
- 208000027312 Bursal disease Diseases 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 48
- 229960004756 ethanol Drugs 0.000 claims description 47
- 239000000243 solution Substances 0.000 claims description 37
- 239000006228 supernatant Substances 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 24
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 22
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 22
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 22
- 238000001914 filtration Methods 0.000 claims description 18
- 230000037396 body weight Effects 0.000 claims description 12
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 9
- 229920000053 polysorbate 80 Polymers 0.000 claims description 9
- 230000003612 virological effect Effects 0.000 claims description 9
- 230000003203 everyday effect Effects 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000003651 drinking water Substances 0.000 claims description 4
- 235000020188 drinking water Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000003405 preventing effect Effects 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 235000011158 Prunus mume Nutrition 0.000 claims description 3
- 244000018795 Prunus mume Species 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 2
- 235000021433 fructose syrup Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- 229960004793 sucrose Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 208000027954 Poultry disease Diseases 0.000 abstract description 4
- 208000002979 Influenza in Birds Diseases 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 26
- 241000287828 Gallus gallus Species 0.000 description 24
- 231100000915 pathological change Toxicity 0.000 description 23
- 230000036285 pathological change Effects 0.000 description 23
- 235000013330 chicken meat Nutrition 0.000 description 22
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 21
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 21
- 229940079593 drug Drugs 0.000 description 20
- 230000004083 survival effect Effects 0.000 description 16
- 235000019786 weight gain Nutrition 0.000 description 16
- 230000004584 weight gain Effects 0.000 description 14
- 208000032843 Hemorrhage Diseases 0.000 description 13
- 210000002969 egg yolk Anatomy 0.000 description 12
- 238000007689 inspection Methods 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 235000013594 poultry meat Nutrition 0.000 description 10
- 210000001669 bursa of fabricius Anatomy 0.000 description 9
- 235000013601 eggs Nutrition 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 241001061264 Astragalus Species 0.000 description 6
- 235000006533 astragalus Nutrition 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 210000004233 talus Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000002349 favourable effect Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 235000021053 average weight gain Nutrition 0.000 description 4
- 229960001172 doxycycline hyclate Drugs 0.000 description 4
- HALQELOKLVRWRI-VDBOFHIQSA-N doxycycline hyclate Chemical compound O.[Cl-].[Cl-].CCO.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O HALQELOKLVRWRI-VDBOFHIQSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000702626 Infectious bursal disease virus Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- 208000008494 pericarditis Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000244186 Ascaris Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 206010071301 Perihepatitis Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000036750 egg laying performance Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 210000002976 pectoralis muscle Anatomy 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- XLYPVOJLUJUWKA-UHFFFAOYSA-N 2-hydroxy-4-methoxy-2-(2-methoxy-2-oxoethyl)-4-oxobutanoic acid Chemical compound COC(=O)CC(O)(C(O)=O)CC(=O)OC XLYPVOJLUJUWKA-UHFFFAOYSA-N 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241000007938 Juquitiba virus Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000270959 Pelophylax nigromaculatus Species 0.000 description 1
- 240000005049 Prunus salicina Species 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000000902 chlamydia Diseases 0.000 description 1
- 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000009018 li Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- -1 oven dry Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229950003874 sulfamonomethoxine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101335555A CN101804112B (zh) | 2010-03-25 | 2010-03-25 | 贯众乌梅中药组合物制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101335555A CN101804112B (zh) | 2010-03-25 | 2010-03-25 | 贯众乌梅中药组合物制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101804112A true CN101804112A (zh) | 2010-08-18 |
CN101804112B CN101804112B (zh) | 2012-07-18 |
Family
ID=42606173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101335555A Expired - Fee Related CN101804112B (zh) | 2010-03-25 | 2010-03-25 | 贯众乌梅中药组合物制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101804112B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102550831A (zh) * | 2012-02-20 | 2012-07-11 | 中国农业大学 | 肉桂酸在制备提高畜禽生长性能的产品中的应用 |
CN102600120A (zh) * | 2012-01-04 | 2012-07-25 | 中国农业大学 | 肉桂酸在制备防治畜禽病毒感染的药物中的应用 |
CN103272024A (zh) * | 2013-04-16 | 2013-09-04 | 阚兆云 | 中药提取物 |
-
2010
- 2010-03-25 CN CN2010101335555A patent/CN101804112B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
《厦门大学学报(自然科学版)》 20060531 张春乐等 肉桂酸及其衍生物的抑菌活性研究 第16-19页 1-2 , 2 * |
《药浴治百病》 19981231 方羽等 手足癣 安徽科学技术出版社 第249页 1-2 , 1 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102600120A (zh) * | 2012-01-04 | 2012-07-25 | 中国农业大学 | 肉桂酸在制备防治畜禽病毒感染的药物中的应用 |
CN102550831A (zh) * | 2012-02-20 | 2012-07-11 | 中国农业大学 | 肉桂酸在制备提高畜禽生长性能的产品中的应用 |
CN102550831B (zh) * | 2012-02-20 | 2015-12-02 | 中国农业大学 | 肉桂酸在制备提高畜禽生长性能的产品中的应用 |
CN103272024A (zh) * | 2013-04-16 | 2013-09-04 | 阚兆云 | 中药提取物 |
Also Published As
Publication number | Publication date |
---|---|
CN101804112B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103006792B (zh) | 一种防治畜禽肠道疾病的中兽药及其制备方法与饲料 | |
CN102151256B (zh) | 原儿茶酸在制备防治畜禽病毒感染性疾病的药物中的应用 | |
CN101007067A (zh) | 用于禽类抗病毒药物及其制备方法 | |
CN101596246B (zh) | 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 | |
CN1879814B (zh) | 禽用抗病毒药物及其制备方法 | |
CN101804112B (zh) | 贯众乌梅中药组合物制备方法及应用 | |
CN101940634A (zh) | 一种治疗鸡大肠杆菌病的中药组合物及其用途 | |
CN104739960B (zh) | 肠胃抗菌药物组合物、含该组合物的肠胃抗菌药物及制备 | |
CN105168374B (zh) | 细果角茴香提取物在制备抗病毒药物中的应用 | |
CN103127198B (zh) | 治疗仔猪黄白痢的联合用药物 | |
CN101259160A (zh) | 治疗禽类病毒性疾病的复方制剂及其制备方法 | |
CN106214862B (zh) | 一种防治鸡非典型性新城疫的中兽药口服液及其制备方法 | |
CN102600120B (zh) | 肉桂酸在制备防治畜禽病毒感染的药物中的应用 | |
CN103417653B (zh) | 一种治疗球虫的兽用复方纯中药及其口服液的制备方法 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN101953962B (zh) | 一种治疗鸡绦虫病的中药、颗粒剂及其制备方法 | |
CN106266317A (zh) | 一种防治雏鸡法氏囊病的中药制剂 | |
CN105535927A (zh) | 一种用于治疗流感、上呼吸道感染、病毒性肺炎的药物 | |
CN105770054A (zh) | 用于防治鸡球虫病的药物组合物、添加剂和饲料 | |
CN104758407A (zh) | 一种治疗火鸡出血性肠炎的中药组合物及其制备方法 | |
CN109498701A (zh) | 一种防治鹅副粘病毒的中药组合物及其制备方法和应用 | |
CN104606627B (zh) | 一种治疗仔猪腹泻的药物组合物及其制备方法 | |
CN108272788B (zh) | 葛根素在制备防治猪病毒感染的药物中的用途、防治猪病毒感染的药物及猪饲料添加剂 | |
CN103656267B (zh) | 一种用于治疗猪蓝耳病的中药组合物及其制备方法和应用 | |
CN102727503A (zh) | 一种从老鹳草中提取的老鹳草素在制备抗疱疹病毒药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180410 Address after: 527100 twelve Town Development Zone, metropolitan Town, Yunan County, Yunfu, Guangdong Patentee after: GUANGDONG TIANBAO BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Address before: 100193 School of veterinary medicine, Kasetsart University, 2 West Old Summer Palace Road, Haidian District, Beijing Co-patentee before: GUANGDONG TIANBAO BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Patentee before: China Agricultural University |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120718 |
|
CF01 | Termination of patent right due to non-payment of annual fee |